This is a study that is being done with Washington State University in collaboration with Dr. Rainer Boger that is comparing Pro-Argi9 to placebo in a 12 week double-blind trial. The study will compare baseline measures of Blood Pressure, CASP, ADMA and LpPlac2 (a vascular specific inflammatory marker) to repeated endpoint measures. Dr. Kathy Beerman (a nutrition professor from WSU) and Gretchen Millard (Registered... Read More












